Mohamed Ndongo Sangare
Overview
Explore the profile of Mohamed Ndongo Sangare including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
11
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sangare M, Baril J, de Pokomandy A, Klein M, Thomas R, Tremblay C, et al.
Clin Infect Dis
. 2023 Feb;
76(11):1879-1888.
PMID: 36722329
Background: The impact of different therapeutic classes of drugs in antiretroviral therapy (ART) regimens on the CD4/CD8 ratio is not well documented in people treated for HIV. The objective of...
2.
Beausejour M, Aubin D, Fortin C, Sangare M, Carignan M, Roy-Beaudry M, et al.
BMC Musculoskelet Disord
. 2022 Aug;
23(1):752.
PMID: 35932044
Purpose: An inclinometer smartphone application has been developed to enable the measurement of the angle of trunk inclination (ATI) to detect trunk surface asymmetry. The objective was to determine the...
3.
Sangare M, Baril J, de Pokomandy A, Laprise C, Deshaies C, Klein M, et al.
Medicine (Baltimore)
. 2020 Nov;
99(47):e23335.
PMID: 33217873
There is uncertainty regarding the potential virologic outcome associated with a change in antiretroviral therapy (ARV) among PLHIV who had previous documented virologic failure or who have been exposure to...
4.
Sangare M, Baril J, de Pokomandy A, Ferreira Guerra S, Carabali M, Laprise C, et al.
Open Forum Infect Dis
. 2020 Nov;
7(11):ofaa404.
PMID: 33204746
Background: Switching antiretroviral regimens when human immunodeficiency virus (HIV) viremia is controlled for a new regimen is challenging when there is the potential for prior nucleoside reverse-transcriptase inhibitor (NRTI) resistance....
5.
Kafando A, Martineau C, El-Far M, Fournier E, Doualla-Bell F, Serhir B, et al.
Viruses
. 2019 Nov;
11(11).
PMID: 31683782
Background: HIV-1 transmitted/founder viruses (TF) are selected during the acute phase of infection from a multitude of virions present during transmission. They possess the capacity to establish infection and viral...
6.
Kafando A, Serhir B, Doualla-Bell F, Fournier E, Sangare M, Martineau C, et al.
AIDS Res Hum Retroviruses
. 2019 Aug;
35(10):906-919.
PMID: 31407606
The identification of transmission clusters (TCs) of HIV-1 using phylogenetic analyses can provide insights into viral transmission network and help improve prevention strategies. We compared the use of partial HIV-1...
7.
Kafando A, Fournier E, Serhir B, Martineau C, Doualla-Bell F, Sangare M, et al.
PLoS One
. 2017 Dec;
12(12):e0189999.
PMID: 29284009
Identifying recent HIV-1 infections is crucial for monitoring HIV-1 incidence and optimizing public health prevention efforts. To identify recent HIV-1 infections, we evaluated and compared the performance of 4 sequence-based...